glp-1 treatments How medications are transforming diabetes and weight loss treatment GLP-1s | AgelessRx

doi: 10.3748/wjg.v30.i48.5205 Summary Keywords crp, GLP-1 RA, IL-6, inflammatory biomarker, MDA, T2D, TNF- Citation Alrasheed T, Mostafa MEA, Madkhali MA and Khairy HA (2026) Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and meta-analysis

doi: 10.1016/j.bone.2019.05.014 21 AsmarMSimonsenLArngrimNHolstJJDelaFBlowJ

GLP-1 agonists have mixed cardiovascular effects

4143 Moreover, MCP-1 (CCL2) mRNA expression was found to increase during the active disease state in endothelial cells and SMCs

It is a major shift in how people approach weight and metabolic health

Additionally, if gastrointestinal side effects from semaglutide (nausea, vomiting) interfere with the ability to take levothyroxine consistently, medical guidance is needed to maintain thyroid control